Mercury Tube is a manufacturer of high precision stainless steel and high nickel alloy tubing
Posted on February 7, 2020
Accu-Tube, a developer of high-quality stainless steel tubing, has acquired Mercury Tube, a global manufacturer of high precision stainless steel and high nickel alloy tubing based nearby in Englewood, Colo. Mercury Tube will operate as a wholly-owned subsidiary of Accu-Tube.
Mercury Tube provides welded and drawn tubing and cold drawn outside diameter tubing in standard and custom sizes ranging from .125” OD (outside diameter) to 1.25” OD. The company’s core alloys include 304/304L, 304H, 316/316L, 321, 400, 800, 825, 840 and E-Brite. In addition, Mercury Tube has the capability to produce small diameter tubing at wall thicknesses ranging from .010” (.25mm) to greater than .083” (2.11mm).
Kevin McGrath, CEO of Accu-Tube said, “We are excited about acquiring Mercury Tube and adding Mercury Tube’s skilled employees and extensive range of tubing capabilities. In particular, Mercury Tube’s ability to weld and draw thicker-walled small diameter tubing will help us broaden our product offering to our medical customers. In the coming months, we expect to have a series of exciting new product introductions that will leverage the unique capabilities of both operations.”
Mercury Tube will continue operating out of its 40,000-square-foot facility in Englewood, Colo. The company’s current customer base includes a diversified group of OEMs and Tier I suppliers in the industrial, aerospace, medical, and thermal management end markets. Accu-Tube will invest in Mercury Tube by adding plug-drawing and centerless grinding technologies to expand capabilities for their customer base.
In the early 1970s, Mercury and Accu-Tube had shared ownership under Gary Oakley. This acquisition reunites the two long-standing providers of precision stainless steel tubing.
Jesse Liu, a Partner at Washington Equity added, “We are excited to support Accu-Tube’s acquisition of Mercury Tube and significant new business opportunities in the medical and aerospace end markets for the combined company.”